ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

McKesson To Purchase US Oncology

November 5, 2010

NTP Staff Members In Bethesda Told They Must Move

December 16, 1983

NCI Cancer Studies In China Intact; Visits Delayed

July 14, 1989

NCI Drops Breast Screening Guidelines, Issues “Summary Of Scientific Fact”

December 10, 1993

Anidulafungin Safe And Well-Tolerated In Pediatric Patients With Neutropenia

November 26, 2004

Molecular target Drug Discovery Grants; Unanimously Approved

July 2, 1999